Kallikrein 14 Antikörper (N-Term)
Kurzübersicht für Kallikrein 14 Antikörper (N-Term) (ABIN953101)
Target
Alle Kallikrein 14 (KLK14) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 14-44, N-Term
-
Spezifität
- This antibody recognizes Human KLK14 / Kallikrein-14 (N-term).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 14-44 amino acids from the N-terminal region of Human KLK14 / Kallikrein-14
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Kallikrein 14 (KLK14)
-
Andere Bezeichnung
- KLK14 / Kallikrein-14
-
Hintergrund
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. An additional transcript variant has been described but its full length nature has not been determined.Synonyms: KLK-L6, KLKL6, Kallikrein-like protein 6
-
Molekulargewicht
- 29122 Da
-
Gen-ID
- 43847
-
NCBI Accession
- NP_071329
-
Pathways
- Komplementsystem, Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-